It is a chemicals private limited company based in Palgarh, Maharashtra, India, established in 2014.
2014 | Palgarh, Maharashtra, India | ActiveCerise Pharmaceuticals Private Limited, a active private limited company, was established on 29 December 2014 in Palgarh, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24132MH2014PTC260450. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
Formerly known as Berry Pharmaceuticals Private Limited, Sunshine Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Shailesh Kumar Pandey (Director), Satya Prakash Pandey (Director). Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at Shop No.1, Chaubey Compound, Sitaram Nagar, Santosh Bhavan, Nallasopara (E.), Palgarh, Maharashtra, 401209.
U24132MH2014PTC260450
260450
29 December 2014
₹0.20 M
₹0.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cerise Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Kumar Pandey | Director | 29 Dec 2014 | Current |
| Satya Prakash Pandey | Director | 29 Dec 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cerise Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Cerise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cerise Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cerise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cerise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Cerise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was documented.
Cerise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was recorded as a recent event.
The activity Shailesh Kumar Pandey was appointed as a Director was appointed as a Director on 29 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
The activity Satya Prakash Pandey was appointed as a Director was appointed as a Director on 29 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
Cerise Pharmaceuticals Private Limited was registered on 29 Dec 2014 with Roc Mumbai & aged 10 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Cerise Pharmaceuticals Private Limited is U24132MH2014PTC260450.
Cerise Pharmaceuticals Private Limited is headquartered at Shop No.1, Chaubey Compound, Sitaram Nagar, Santosh Bhavan, Nallasopara (E.), Palgarh, Maharashtra, 401209.
Cerise Pharmaceuticals Private Limited was incorporated on 29 December 2014.
The current directors of Cerise Pharmaceuticals Private Limited are
The primary industry of Cerise Pharmaceuticals Private Limited is Chemicals.
Cerise Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cerise Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
The compliance status of Cerise Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX